Recommended Topic Related To:

Gabitril

"The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

Epilepsy is a brain disorder caused by abnormal or excessive activity in the brain"...

Gabitril

Gabitril

INDICATIONS

GABITRIL (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures.

DOSAGE AND ADMINISTRATION

General

The blood level of tiagabine obtained after a given dose depends on whether the patient also is receiving a drug that induces the metabolism of tiagabine. The presence of an inducer means that the attained blood level will be substantially reduced. Dosing should take the presence of concomitant medications into account.

  • GABITRIL (tiagabine hydrochloride) (tiagabine HC1) is recommended as adjunctive therapy for the treatment of partial seizures in patients 12 years and older.
  • The following dosing recommendations apply to all patients taking GABITRIL (tiagabine hydrochloride) :
  • GABITRIL (tiagabine hydrochloride) is given orally and should be taken with food.
  • Do not use a loading dose of GABITRIL (tiagabine hydrochloride) .
  • Dose titration: Rapid escalation and/or large dose increments of GABITRIL (tiagabine hydrochloride) should not be used.
  • Missed dose(s): If the patient forgets to take the prescribed dose of GABITRIL (tiagabine hydrochloride) at the scheduled time, the patient should not attempt to make up for the missed dose by increasing the next dose. If a patient has missed multiple doses, patient should refer back to his or her physician for possible re-titration as clinically indicated.
  • Dosage adjustment of GABITRIL (tiagabine hydrochloride) should be considered whenever a change in patient's enzyme-inducing status occurs as a result of the addition, discontinuation, or dose change of the enzyme-inducing agent.

Induced Adults and Adolescents 12 Years or Older: The following dosing recommendations apply to patients who are already taking enzyme-inducing antiepilepsy drugs (AEDs) (e.g., carbamazepine, phenytoin, primidone, and phenobarbital). Such patients are considered induced patients when administering GABITRIL (tiagabine hydrochloride) .

In adolescents 12 to 18 years old, GABITRIL (tiagabine hydrochloride) should be initiated at 4 mg once daily. Modification of concomitant antiepilepsy drugs is not necessary, unless clinically indicated. The total daily dose of GABITRIL (tiagabine hydrochloride) may be increased by 4 mg at the beginning of Week 2. Thereafter, the total daily dose may be increased by 4 to 8 mg at weekly intervals until clinical response is achieved or up to 32 mg/day. The total daily dose should be given in divided doses two to four times daily. Doses above 32 mg/day have been tolerated in a small number of adolescent patients for a relatively short duration.

In adults, GABITRIL (tiagabine hydrochloride) should be initiated at 4 mg once daily. Modification of concomitant antiepilepsy drugs is not necessary, unless clinically indicated. The total daily dose of GABITRIL (tiagabine hydrochloride) may be increased by 4 to 8 mg at weekly intervals until clinical response is achieved or, up to 56 mg/day. The total daily dose should be given in divided doses two to four times daily. Doses above 56 mg/day have not been systematically evaluated in adequate and well-controlled clinical trials.

Experience is limited in patients taking total daily doses above 32 mg/day using twice daily dosing. A typical dosing titration regimen for patients taking enzyme-inducing AEDs (induced patients) is provided in Table 7.

Table 7: Typical Dosing Titration Regimen for Patients Already Taking Enzyme-Inducing AEDs

  Initiation and Titration Schedule Total Daily Dose
Week l Initiate at 4 mg once daily 4 mg/day
Week 2 Increase total daily dose by 4 mg 8 mg/day (in two divided doses)
WeekS Increase total daily dose by 4 mg 12 mg/day (in three divided doses)
Week 4 Increase total daily dose by 4 mg 16 mg/day (in two to four divided doses)
WeekS Increase total daily dose by 4 to 8 mg 20 to 24 mg/day (in two to four divided doses)
Week 6 Increase total daily dose by 4 to 8 mg 24 to 32 mg/day (in two to four divided doses)
Usual Adult Maintenance Dose in Induced Patients: 32 to 56 mg/day in two to four divided doses

Non-Induced Adults and Adolescents 12 Years or Older: The following dosing recommendations apply to patients who are taking only non-enzyme-inducing AEDs. Such patients are considered non-induced patients:

Following a given dose of GABITRIL (tiagabine hydrochloride) , the estimated plasma concentration in the non-induced patients is more than twice that in patients receiving enzyme-inducing agents. Use in non-induced patients requires lower doses of GABITRIL (tiagabine hydrochloride) . These patients may also require a slower titration of GABITRIL (tiagabine hydrochloride) compared to that of induced patients (see CLINICAL PHARMACOLOGY, Pharmacokinetics and PRECAUTIONS, General, Use in Non-Induced Patients).

HOW SUPPLIED

GABITRIL (tiagabine hydrochloride) tablets are available in four dosage strengths.

2 mg orange-peach, round tablets, debossed with liSl on one side and 402 on the opposite side, are available in bottles of 30 (NDC 63459-402-30).

4 mg yellow, round tablets, debossed with liSl on one side and 404 on the opposite side, are available in bottles of 30 (NDC 63459-404-30).

12 mg green, ovaloid tablets, debossed with li£zl on one side and 412 on the opposite side, are available in bottles of 30 (NDC 63459-412-30).

16 mg blue, ovaloid tablets, debossed with liSl on one side and 416 on the opposite side, are available in bottles of 30 (NDC 63459-416-30).

Recommended Storage: Store tablets at controlled room temperature, between 20-25°C (68-77°F). See USP. Protect from light and moisture.

Distributed by: Cephalon, Inc. Frazer, PA 19355. Revised: September 2010.

>This Medication Guide has been approved by the U.S. Food and Drug Administration.

Last reviewed on RxList: 11/5/2010
This monograph has been modified to include the generic and brand name in many instances.

A A A

Gabitril - User Reviews

Gabitril User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Gabitril sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Epilepsy

Find tips and treatments to control seizures.

Related Supplements
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations